Drug details

Vosevi (sofosbuvir)

type of Hepatitis B Hepatitis C Agents, HCV Polymerase Inhibitors

Vosevi (sofosbuvir, velpatasvir, and voxilaprevir) tablets are a fixed-dose combination of a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor, an HCV NS5A inhibitor, and an HCV NS3/4A protease inhibitor, indicated for the treatment of adult patients with chronic HCV infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an HCV regimen containing an NS5A inhibitor; or genotype 1a or 3 infection and have previously been treated with an HCV regimen containing sofosbuvir without an NS5A inhibitor.

The drug is often used to treat Cirrhosis , Hepatitis C .

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• loss of appetite,
• dark urine,
• vomiting,
• diarrhea,
• easy bruising,
• unusual bleeding,
• lightheadedness,
• shortness of breath,
• confusion,
• tiredness,
• chest pain,
• weakness, and
• right-sided upper stomach pain,
• memory problems,
• yellowing of your skin or eyes (jaundice),
• very slow heartbeats,
• black or bloody stools,
• vomiting blood,
• extreme tiredness

The following drugs are related to Vosevi, either as a replacement or used together:

• Moderiba (ribavirin tablets)